Dissemination in Time and Space in Multiple Sclerosis
"Dissemination in space" means MS lesions must occur in multiple distinct anatomical locations of the central nervous system, while "dissemination in time" means lesions must develop at different time points, proving the disease is ongoing and not a single isolated event. 1
Dissemination in Space (DIS)
Dissemination in space demonstrates that MS affects multiple areas of the CNS simultaneously. According to the International Panel diagnostic criteria, this requires evidence of lesions in at least 2 of the following anatomical regions 1:
- Periventricular (around the ventricles)
- Juxtacortical or cortical (at or near the brain's outer surface)
- Infratentorial (brainstem or cerebellum)
- Spinal cord
The 2024 McDonald criteria now include a fifth location: the optic nerve, expanding diagnostic capabilities 2. Recent evidence suggests that when lesions are present in ≥4 of these regions, DIS alone may be sufficient for diagnosis with extremely high specificity (100%), potentially eliminating the need for demonstrating dissemination in time 3.
How DIS Can Be Demonstrated:
- MRI findings meeting specific criteria (Barkhof criteria) 1
- Clinical evidence of lesions in different CNS locations
- Alternative approach: At least 2 brain lesions OR 1 brain + 1 spinal cord lesion consistent with MS, plus positive CSF (oligoclonal bands or elevated IgG index) 1
Dissemination in Time (DIT)
Dissemination in time proves the disease is active over time rather than a single monophasic event. This requires a minimum 3-month interval between clinical events or MRI evidence of new lesion development 1.
How DIT Can Be Demonstrated:
On MRI 1:
- If first scan is ≥3 months after clinical event: A gadolinium-enhancing lesion at a different site than the original clinical event fulfills DIT
- If no enhancing lesion: A follow-up scan (recommended at 3 months) showing new T2 or gadolinium-enhancing lesions fulfills DIT
- Simultaneous presence of both enhancing and non-enhancing lesions on a single baseline MRI can demonstrate DIT
Clinically:
- A second clinical attack occurring at least 3 months after the first, affecting a different CNS location 1
CSF alternative:
- Positive oligoclonal bands (different from serum) or elevated IgG index can substitute for MRI evidence of DIT 3
Clinical Application Algorithm
For patients with one clinical attack:
- If 2+ lesions on exam: Need only DIT (via MRI or second attack) 1
- If 1 lesion on exam: Need both DIS (via MRI) AND DIT (via MRI or second attack) 1
- If lesions in ≥4/5 regions (including optic nerve): Consider diagnosis without requiring DIT, given 100% specificity 3
For patients with 2+ clinical attacks:
- If 2+ lesions on exam: No additional testing required if attacks are separated in time and space 1
- If 1 lesion on exam: Need only DIS (via MRI or await another attack at different site) 1
Critical Pitfalls to Avoid
- The 3-month interval is crucial to avoid misdiagnosing acute disseminated encephalomyelitis (ADEM), which can have a stuttering onset 1
- Gadolinium-enhancing lesions used for DIT must be at a different site than the original clinical event 1
- Always exclude alternative diagnoses - even with perfect DIS and DIT criteria, there must be no better explanation than MS 1
- Cortical lesions are now equivalent to juxtacortical lesions for DIS criteria, and symptomatic lesions can be counted (unlike earlier criteria) 2
- Spinal cord lesions can substitute for brain lesions in meeting DIS criteria 1
The fundamental principle remains: MS diagnosis requires proving the disease affects multiple CNS locations (space) and occurs over time, distinguishing it from single isolated events or other conditions that may mimic MS 1, 4.